Target intelligence / Profile preview

Sestrin-3 (SESN3)

Target
SESN3
Molecular classification
Other (stress-induced protein), Metabolic regulator
01

Overview

Sestrin-3 (SESN3) is a member of the sestrin family of stress-induced proteins that regulates cellular responses to oxidative and genotoxic stress by decreasing intracellular reactive oxygen species levels[1][4]. It plays a crucial role in maintaining glucose and lipid homeostasis, modulating insulin sensitivity, and controlling lipid storage, with particular significance in metabolic tissues such as the liver[2][4]. SESN3 acts as a metabolic regulator through negative feedback of the mTORC1 signaling pathway and positive activation of mTORC2/Akt signaling, thereby influencing cellular metabolism and stress adaptation[2][4]. It also functions in neuroinflammation, modulating pro-inflammatory cytokine expression and has been linked to neurological disorders like epilepsy[3]. No specific drugs targeting Sestrin-3 are currently available, but its central regulatory functions make it an attractive candidate for future therapeutic intervention in metabolic, inflammatory, and neurodegenerative diseases[2][3][4].

Other names
Sestrin 3SESN3SEST3MGC29667sestrin-3
02

Mechanism of action

Not applicable (Direct mechanisms of action for drugs not established; SESN3 instead acts through regulation of mTORC1/2 pathways and modulation of oxidative stress[2][4])

03

Biological functions

Reduction of reactive oxygen species (ROS)Regulation of insulin sensitivityModulation of lipid storageRegulation of glucose homeostasisResponse to oxidative and genotoxic stressModulation of mTORC1 and mTORC2 signaling pathwaysRegulation of inflammatory responses
04

Disease associations

Diabetes/Insulin resistanceObesity/metabolic syndromeNeurodegenerative diseaseEpilepsyEndometrial adenosquamous carcinomaInflammation
05

Safety considerations

Not specifically documented; potential modulating role in inflammation and metabolic regulation implies broad systemic effects if targeted
06

Biomarkers

Possible candidate for monitoring insulin resistance, glucose homeostasis, and neuroinflammation, but not established clinical biomarker

Beyond the preview

Go deeper on Sestrin-3 (SESN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sestrin-3 (SESN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call